LEO Pharma Acquires Dersimelagon for Rare Skin Diseases
BALLERUP, DENMARK, August 18, 2026 LEO Pharma has entered into an agreement to acquire worldwide rights to dersimelagon from...
acute myeloid leukemia
Advertisement
Smith+Nephew and Imperial Advance Surgical Robotics
LONDON, August 18, 2026 Smith+Nephew and Imperial College London have launched a new five-year partnership to accelerate innovation in...
InnoCare Advances Phase III AML Trial of Mesutoclax
BEIJING, August 18, 2026 InnoCare Pharma announced that China’s Center for Drug Evaluation (CDE) of the National Medical Products...
BrainStorm Advances NurOwn ALS Program Toward Phase 3b
New York, United States, August 14, 2026 BrainStorm Cell Therapeutics Inc. announced its financial results for the second quarter...
Kyowa Kirin Advances AI-Powered Drug Discovery R&D
Tokyo, Japan, August 16, 2026 Kyowa Kirin Co., Ltd. has selected Cognizant and Benchling as partners to implement an...
Advertisements
Actinium Advances Actimab-A With Manufacturing Expansion
New York, United States, August 14, 2026 Actinium Pharmaceuticals, Inc. announced new intellectual property and manufacturing developments supporting its...
Kura Oncology Publishes Ziftomenib Data in Blood
SAN DIEGO, August 10, 2026 Kura Oncology, Inc. announced the publication of new research in Blood detailing the discovery...
Acarix Wins UAE Approval for AI-Powered CADScor System
United Arab Emirates, August 10, 2026 Acarix AB has announced that its CADScor® System, an artificial intelligence-enabled point-of-care diagnostic...
Innovent and Daiichi Sankyo Partner on VANFLYTA in China
SAN FRANCISCO, USA and SUZHOU, China, August 9, 2026 Innovent Biologics and Daiichi Sankyo have entered into an exclusive...
Nabsys Partners With Indiana University on Cancer Genomics
PROVIDENCE, R.I., July 31, 2026 Nabsys 2.0, LLC has entered into a multi-year research collaboration with Indiana University School...
Advertisement
